Anthem (NYSE:ANTM) had its price objective upped by equities researchers at Morgan Stanley from $359.00 to $371.00 in a report issued on Friday, BenzingaRatingsTable reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s price target would suggest a potential upside of 19.98% from the stock’s previous close.
Several other equities analysts have also issued reports on the company. Zacks Investment Research lowered G1 Therapeutics from a “buy” rating to a “hold” rating in a research report on Thursday, May 16th. UBS Group set a $36.00 price objective on Halliburton and gave the company a “buy” rating in a research report on Tuesday, April 23rd. SunTrust Banks reiterated a “hold” rating and issued a $44.00 price objective on shares of Shutterstock in a research report on Thursday, April 25th. Citigroup reiterated a “buy” rating on shares of Healthequity in a research report on Friday, May 10th. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $75.00 price objective on shares of Emergent Biosolutions in a research report on Sunday, April 21st. Two analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Anthem currently has a consensus rating of “Buy” and an average price target of $325.67.
Shares of Anthem stock traded up $5.33 during trading on Friday, hitting $309.21. 60,637 shares of the company were exchanged, compared to its average volume of 1,295,649. The company has a market capitalization of $74.05 billion, a price-to-earnings ratio of 19.45, a P/E/G ratio of 1.01 and a beta of 0.70. Anthem has a 1-year low of $227.16 and a 1-year high of $317.99. The stock has a fifty day moving average price of $282.70. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.61 and a quick ratio of 1.61.
Anthem (NYSE:ANTM) last issued its quarterly earnings data on Wednesday, April 24th. The company reported $6.03 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $5.86 by $0.17. Anthem had a return on equity of 14.99% and a net margin of 4.23%. The business had revenue of $24.39 billion during the quarter, compared to analyst estimates of $24.31 billion. During the same period in the previous year, the firm earned $5.41 EPS. Anthem’s quarterly revenue was up 9.2% compared to the same quarter last year. Sell-side analysts predict that Anthem will post 19.29 EPS for the current year.
In other Anthem news, EVP Thomas C. Zielinski sold 8,826 shares of the business’s stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $283.92, for a total value of $2,505,877.92. Following the sale, the executive vice president now owns 33,183 shares in the company, valued at approximately $9,421,317.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Ramiro G. Peru sold 1,656 shares of the business’s stock in a transaction that occurred on Tuesday, May 21st. The shares were sold at an average price of $275.00, for a total value of $455,400.00. Following the completion of the sale, the director now owns 11,173 shares in the company, valued at approximately $3,072,575. The disclosure for this sale can be found here. Insiders sold a total of 11,245 shares of company stock worth $3,174,155 in the last 90 days. Company insiders own 0.17% of the company’s stock.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ANTM. Destination Wealth Management bought a new stake in shares of Anthem during the 1st quarter worth approximately $31,000. Lee Financial Co bought a new stake in shares of Anthem during the 1st quarter worth approximately $32,000. Liberty Wealth Management LLC bought a new stake in shares of Anthem during the 1st quarter worth approximately $36,000. Cable Hill Partners LLC raised its stake in shares of Anthem by 77.5% during the 1st quarter. Cable Hill Partners LLC now owns 126 shares of the company’s stock worth $36,000 after purchasing an additional 55 shares in the last quarter. Finally, Executive Wealth Management LLC bought a new stake in shares of Anthem during the 1st quarter worth approximately $46,000. Hedge funds and other institutional investors own 87.11% of the company’s stock.
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Further Reading: Compound Interest and Why It Matters When Investing
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.